Genscript Biotech Corporation Market Cap ($3.36 Billion)
Market Cap & Net Worth: Genscript Biotech Corporation (G51)
Genscript Biotech Corporation market cap. Genscript Biotech Corporation (F:G51) has a market capitalization of $3.36 Billion (€2.88 Billion) as of November 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #4429 globally and #776 in its home market, demonstrating a 8.20% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Genscript Biotech Corporation's stock price €3.96 by its total outstanding shares 2184705170 (2.18 Billion). Also see Genscript Biotech Corporation cash flow conversion for how efficiently the company converts equity into cash flow.
Genscript Biotech Corporation Market Cap History (2016–2026)
Genscript Biotech Corporation market cap history from 2016 to 2026. Data shows growth from $1.10 Billion to $10.11 Billion (36.77% CAGR). Check Genscript Biotech Corporation stock price for real-time trading data and today's change.
Genscript Biotech Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Genscript Biotech Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Genscript Biotech Corporation to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
3.52x
Genscript Biotech Corporation's market cap is 3.52 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.10 Billion | $114.73 Million | $26.17 Million | 9.61x | 42.14x |
| 2017 | $5.44 Billion | $152.65 Million | $26.12 Million | 35.64x | 208.26x |
| 2018 | $2.91 Billion | $231.02 Million | $21.22 Million | 12.60x | 137.24x |
| 2019 | $5.16 Billion | $273.35 Million | -$96.91 Million | 18.87x | N/A |
| 2020 | $2.94 Billion | $390.33 Million | -$204.94 Million | 7.53x | N/A |
| 2021 | $9.09 Billion | $510.60 Million | -$347.87 Million | 17.81x | N/A |
| 2022 | $7.53 Billion | $625.70 Million | -$226.85 Million | 12.04x | N/A |
| 2023 | $5.68 Billion | $560.48 Million | -$95.48 Million | 10.14x | N/A |
| 2024 | $3.06 Billion | $594.49 Million | $2.96 Billion | 5.16x | 1.03x |
| 2025 | $3.38 Billion | $959.53 Million | -$532.83 Million | 3.52x | N/A |
Competitor Companies of G51 by Market Capitalization
Companies near Genscript Biotech Corporation in the global market cap rankings as of November 1, 2026. Also see Genscript Biotech Corporation asset portfolio for a full breakdown of the balance sheet.
Key companies related to Genscript Biotech Corporation by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Genscript Biotech Corporation (2016–2026)
Market capitalization of Genscript Biotech Corporation from 2016 to today. Between 2016 and today, Genscript Biotech Corporation's market cap moved from $1.10 Billion to $ 10.11 Billion, with a yearly change of 36.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €10.11 Billion | +199.55% |
| 2025 | €3.38 Billion | +10.17% |
| 2024 | €3.06 Billion | -46.07% |
| 2023 | €5.68 Billion | -24.55% |
| 2022 | €7.53 Billion | -17.16% |
| 2021 | €9.09 Billion | +209.57% |
| 2020 | €2.94 Billion | -43.07% |
| 2019 | €5.16 Billion | +77.19% |
| 2018 | €2.91 Billion | -46.48% |
| 2017 | €5.44 Billion | +393.28% |
| 2016 | €1.10 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Genscript Biotech Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.36 Billion USD |
| MoneyControl | $3.36 Billion USD |
| MarketWatch | $3.36 Billion USD |
| marketcap.company | $3.36 Billion USD |
| Reuters | $3.36 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Genscript Biotech Corporation
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products segments. The Life Scien… Read more